| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.1M | +24.6% |
| R&D Expense | $14.6M | +13.9% |
| SG&A Expense | $21.9M | -12.0% |
| Operating Income | -$49.9M | +11.7% |
| Pre-tax Income | -$46.9M | +10.6% |
| Income Tax | $22K | -29.0% |
| Net Income | -$46.9M | +10.6% |
| EPS (Basic) | -$1.08 | +11.5% |
| EPS (Diluted) | -$1.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.9M | -30.4% |
| Accounts Receivable | $7.5M | +35.9% |
| Inventory | $20.2M | +1.2% |
| Current Assets | $80.9M | -32.8% |
| Total Assets | $98.2M | -31.6% |
| Current Liabilities | $17.6M | -7.5% |
| Total Liabilities | $22.8M | -10.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.2M | +2.1% |
| Capital Expenditures | $1.4M | -26.0% |
| Investing Cash Flow | $36.7M | -13.0% |
| Financing Cash Flow | $203K | +36.2% |
| Free Cash Flow | -$45.5M | +3.0% |
| +11.5% |
| Stockholders' Equity |
| $75.4M |
| -36.1% |